Attorneys general around the country announced a multistate settlement in which Johnson & Johnson and its subsidiary Ethicon Inc. will pay roughly $116.9 million to resolve allegations of deceptive marketing of transvaginal surgical mesh devices.

Under the settlement, Johnson & Johnson has agreed to pay that total to 41 participating states and the District of Columbia, AGs said.